Both Runx2 and RANKL expressions increased along with the progression of NAFLD, which were moderately elevated in the early stage of NAFLD and obviously aggravated in NASH. The gene discussed is TNFSF11; the disease is metabolic dysfunction-associated steatotic liver disease.